Biotica Technology Overview
- Founded
-
1996

- Status
-
Acquired/Merged
- Employees
-
36

- Latest Deal Type
-
M&A
- Investors
-
1
Biotica Technology General Information
Description
Developer of of drugs for the treatment of cancer and inflammatory diseases. The company applies its technology to discover novel therapeutics based on polyketide leads, including mTOR inhibitors, Hsp90 inhibitors, apoptosis inducers and angiogenesis inhibitors.
Contact Information
Primary Office
- 3 Riverside
- Suite 5, Granta Park, Great Abington
- Cambridge CB21 6AD
- England, United Kingdom
+44 01223 000000
Biotica Technology Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Merger/Acquisition | 11-Mar-2013 | 000.00 | Completed | Generating Revenue | ||
2. Early Stage VC (Series B) | 06-Jan-2005 | 00.00 | 000.00 | Completed | Generating Revenue | |
1. Early Stage VC (Series A) | 06-Jan-2003 | $5M | $5M | Completed | Product Development |
Biotica Technology Patents
Biotica Technology Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
GB-201202060-D0 | Novel compounds and methods for their production | Inactive | 07-Feb-2012 | ||
GB-201113626-D0 | Novel compounds and methods for their production | Inactive | 08-Aug-2011 | ||
GB-201113629-D0 | Novel compounds and methods for their production | Inactive | 08-Aug-2011 | ||
GB-201105293-D0 | Novel compounds and methods for their production | Inactive | 29-Mar-2011 | ||
GB-201101085-D0 | Novel compounds | Inactive | 21-Jan-2011 |
Biotica Technology Signals
Biotica Technology Former Investors (3)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
BVF Partners | Hedge Fund | Minority | 000 0000 | 000000 0 | |
Investment 10 | Other | Minority | 000 0000 | 000000 0 | |
NB Capital | Venture Capital | Minority | 000 0000 | 000000 0 |